REUTERS: GlaxoSmithKline has started a trial to test an experimental rheumatoid arthritis drug on patients suffering from COVID-19 related pneumonia, after screening its drugs for potential in the fight against the coronavirus. Drug otilimab – in which GSK acquired rights from German biotech firm …
